Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alona Rehulkova

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|February 25, 2023
Recent Advances in Methods for Circulating Tumor Cell DetectionMonika Vidlarova, Alona Rehulkova, Pavel Stejskal, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|August 20, 2025
Minimal residual disease and prognostic significance of circulating tumour cells in early-stage colorectal cancerBenjamin Tolmaci, Pavel Stejskal, Peter Zuffa, et al.
Neurosurgery|March 4, 2020
Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA ProfilingHanus Slavik, Vladimir Balik, Jana Vrbkova, et al.
Neurosurgery|May 13, 2022
Transcriptomic Profiling Revealed Lnc-GOLGA6A-1 as a Novel Prognostic Biomarker of Meningioma RecurrenceHanus Slavik, Vladimir Balik, Filip Zavadil Kokas, et al.
Journal of Clinical Medicine|August 6, 2020
Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical ResectionNatalia Gablo, Karolina Trachtova, Vladimir Prochazka, et al.
Translational Lung Cancer Research|November 17, 2022
Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survivalMonika Vidlarova, Emil Berta, Petr Prasil, et al.
Translational Lung Cancer Research|June 16, 2023
Clinical and prognostic significance of detecting <i>CEA</i>, <i>EGFR</i>, <i>LunX</i>, <i>c-met</i> and <i>EpCAM</i> mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patientsAlona Rehulkova, Josef Chudacek, Andrea Prokopova, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|February 25, 2023
Recent Advances in Methods for Circulating Tumor Cell DetectionMonika Vidlarova, Alona Rehulkova, Pavel Stejskal, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|August 20, 2025
Minimal residual disease and prognostic significance of circulating tumour cells in early-stage colorectal cancerBenjamin Tolmaci, Pavel Stejskal, Peter Zuffa, et al.
Neurosurgery|March 4, 2020
Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA ProfilingHanus Slavik, Vladimir Balik, Jana Vrbkova, et al.
Neurosurgery|May 13, 2022
Transcriptomic Profiling Revealed Lnc-GOLGA6A-1 as a Novel Prognostic Biomarker of Meningioma RecurrenceHanus Slavik, Vladimir Balik, Filip Zavadil Kokas, et al.
Journal of Clinical Medicine|August 6, 2020
Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical ResectionNatalia Gablo, Karolina Trachtova, Vladimir Prochazka, et al.
Translational Lung Cancer Research|November 17, 2022
Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survivalMonika Vidlarova, Emil Berta, Petr Prasil, et al.
Translational Lung Cancer Research|June 16, 2023
Clinical and prognostic significance of detecting <i>CEA</i>, <i>EGFR</i>, <i>LunX</i>, <i>c-met</i> and <i>EpCAM</i> mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patientsAlona Rehulkova, Josef Chudacek, Andrea Prokopova, et al.
Pageof 1